Sodium Polystyrene Sulfonate
Sodium Polystyrene Sulfonate Powder for Suspension Cation - Exchange Resin Rx only
Approved
Approval ID
806b330b-6564-41c9-a87c-2d68a42e696a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 22, 2019
Manufacturers
FDA
LOHXA
DUNS: 079872715
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sodium Polystyrene Sulfonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70166-712
Application NumberANDA090313
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Polystyrene Sulfonate
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateOctober 22, 2019
FDA Product Classification
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 4.1 meq in 1 g
Code: 1699G8679Z
Classification: ACTIR